Скачать или смотреть China’s Biotech Boom: Outperforming Globally and Raising $11 Billion；PPE Scandal Unveiled: Millions

Welcome to our《Wall Street News Briefing》program! Today, we're diving into China's booming biotech industry, which is catching the world's eye with its innovative drug development and impressive investment surge. Chinese firms like Akeso are making headlines by outpacing global competitors, and the country is pouring over $11 billion into biotech ventures this year alone. But, while progress is exciting, experts advise caution, noting there’s still a long road ahead for China to become a true global leader in groundbreaking therapies.

Next up, a scandal involving PPE Medpro, a company linked to prominent figures like Baroness Mone. The company received government funds for PPE supplies but ended up passing most of that money to other firms. Now, they're being ordered to repay over £122 million for gowns that failed safety standards. With assets just over £666,000, the company's future looks uncertain, and investigations are underway to recover the funds, including a probe by the National Crime Agency.

Finally, in the US, the government shutdown has paused the release of critical job market data, leaving economists and policymakers in the dark. Without the latest employment and wage figures, it's tough to gauge the true state of the economy, especially as recent signs point to a slowing job market. This pause could impact business decisions and delay economic recovery efforts, making the coming weeks even more uncertain. Please continue to stay tuned for more details!

#IPO #ChinaEconomy #Stock #Market #Nasdaq #ChinaStocks #Dow #Invest #LiKeqiang #Money